Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruitao Lin

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Statistics in Biopharmaceutical Research|August 22, 2025
Isotonic Phase I cancer clinical trial design utilizing patient-reported outcomesNolan A Wages, Ruitao Lin
Statistics in Medicine|September 21, 2022
BOB: Bayesian optimal design for biosimilar trials with co-primary endpointsXiaohan Chi, Zhangsheng Yu, Ruitao Lin
Pharmaceutical Statistics|February 9, 2023
Bayesian single-to-double arm transition design using both short-term and long-term endpointsTianlin Xu, Haolun Shi, Ruitao Lin
Biometrics|September 9, 2024
High-dimensional multivariate analysis of variance via geometric median and bootstrappingGuanghui Cheng, Ruitao Lin, Liuhua Peng
Biometrical Journal. Biometrische Zeitschrift|May 13, 2024
Comparative review of novel model-assisted designs for phase I/II clinical trialsHaolun Shi, Ruitao Lin, Xiaolei Lin
Biostatistics (Oxford, England)|July 23, 2021
Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trialsRuitao Lin, Guosheng Yin, Haolun Shi
Therapeutic Innovation & Regulatory Science|August 20, 2025
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug CombinationsXiaohan Chi, Ying Yuan, Ruitao Lin
Biometrics|June 24, 2025
COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapiesXiaohan Chi, Ruitao Lin, Ying Yuan
Pharmaceutical Statistics|May 19, 2021
The use of local and nonlocal priors in Bayesian test-based monitoring for single-arm phase II clinical trialsYanhong Zhou, Ruitao Lin, J Jack Lee
Journal of the American Statistical Association|May 18, 2022
BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival ComparisonsRuitao Lin, Peter F Thall, Ying Yuan
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Statistics in Biopharmaceutical Research|August 22, 2025
Isotonic Phase I cancer clinical trial design utilizing patient-reported outcomesNolan A Wages, Ruitao Lin
Statistics in Medicine|September 21, 2022
BOB: Bayesian optimal design for biosimilar trials with co-primary endpointsXiaohan Chi, Zhangsheng Yu, Ruitao Lin
Pharmaceutical Statistics|February 9, 2023
Bayesian single-to-double arm transition design using both short-term and long-term endpointsTianlin Xu, Haolun Shi, Ruitao Lin
Biometrics|September 9, 2024
High-dimensional multivariate analysis of variance via geometric median and bootstrappingGuanghui Cheng, Ruitao Lin, Liuhua Peng
Biometrical Journal. Biometrische Zeitschrift|May 13, 2024
Comparative review of novel model-assisted designs for phase I/II clinical trialsHaolun Shi, Ruitao Lin, Xiaolei Lin
Biostatistics (Oxford, England)|July 23, 2021
Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trialsRuitao Lin, Guosheng Yin, Haolun Shi
Therapeutic Innovation & Regulatory Science|August 20, 2025
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug CombinationsXiaohan Chi, Ying Yuan, Ruitao Lin
Biometrics|June 24, 2025
COCA: a randomized Bayesian design integrating dose optimization and component contribution assessment for combination therapiesXiaohan Chi, Ruitao Lin, Ying Yuan
Pharmaceutical Statistics|May 19, 2021
The use of local and nonlocal priors in Bayesian test-based monitoring for single-arm phase II clinical trialsYanhong Zhou, Ruitao Lin, J Jack Lee
Journal of the American Statistical Association|May 18, 2022
BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival ComparisonsRuitao Lin, Peter F Thall, Ying Yuan
Pageof 10